Evommune, Inc. (EVMN) stock
EVMNNYSEPharmaceutical PreparationsFiscal year ends December 31
$8.02−0.60 (-6.96%)
Close on Nov 12, 2026Market cap $291.06MP/E –Yield –
Evommune total assets
Total assets on the balance sheet at the end of each period.
Evommune's total assets was $278.30M at Sep 30, 2026. For fiscal 2025 it was $224.95M, up 195.8% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $224.95M | +195.8% |
| FY2024 | Dec 31, 2024 | $76.06M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $278.30M | +229.2% |
| Q2 FY2026 | Jun 30, 2026 | $301.95M | +297.0% |
| Q1 FY2026 | Mar 31, 2026 | $322.46M | – |
| Q4 FY2025 | Dec 31, 2025 | $224.95M | – |
| Q3 FY2025 | Sep 30, 2025 | $84.54M | – |
| Q4 FY2024 | Dec 31, 2024 | $76.06M | – |
See a number that looks wrong?